Single-photon emission computed tomographic findings and motor neuron signs in amyotrophic lateral sclerosis
Creators
- 1. Aichi Medical Univ., Nagakute (Japan)
Description
123I-amphetamine-single photon emission computed tomography (SPECT) was performed on 16 patients with amyotrophic lateral sclerosis (ALS) to investigate the correlation between regional cerebral blood flow (rCBF) and upper motor neuron signs. Significant decreased blood flow less than 2 SDs below the mean of controls was observed in the frontal lobe in 4 patients (25%) and in the frontoparietal lobe including the cortical motor area in 4 patients, respectively. The severity of extermity muscular weakness was significantly correlate with decrease in blood flow through the frontal lobe (p<0.05) and through the frontoparietal lobe (p<0.001). A significant correlation was also noted to exist between the severity of bulbar paralysis and decrease in blood flow through the frontoparietal lobe. No correlation, however, was observed between rCBF and severity of spasticity, presence or absence of Babinski's sign and the duration of illness. Although muscular weakness in the limbs and bulbar paralysis are not pure upper motor neuron signs, the observed reduction in blood flow through the frontal or frontoparietal lobes appears to reflect extensive progression of functional or organic lesions of cortical neurons including the motor area. (author)
Additional details
Publishing Information
- Journal Title
- Aichi Ika Daigaku Igakkai Zasshi
- Journal Volume
- 23
- Journal Issue
- 2
- Journal Page Range
- p. 231-236.
- ISSN
- 0301-0902
- CODEN
- AIDZAC
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 27008088
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BENZEDRINE; BLOOD FLOW; CEREBRUM; IODINE 123; MUSCLES; NERVE CELLS; NERVOUS SYSTEM DISEASES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; VASCULAR DISEASES
- Descriptors DEC
- AMINES; AMPHETAMINES; ANALEPTICS; ANIMAL CELLS; AUTONOMIC NERVOUS SYSTEM AGENTS; BETA DECAY RADIOISOTOPES; BODY; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; NERVOUS SYSTEM; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; RADIOISOTOPES; SOMATIC CELLS; SYMPATHOMIMETICS; TOMOGRAPHY